Tizanidine Tablet
Product Images NDC 0904-6418

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 0904-6418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C60e85a2 4d5a 4507 B577 7ab40184df0b 00

This is a product label for Tizanidine tablets, USP from the pharmaceutical company MAJOR. The medicine is only available by prescription and comes in a unit dose of 100 tablets. The NDC number for this product is 0904-6418-61. The label warns against making any changes to the medicine and also features the names Copaenor Zanstex and capaien. The rest of the text is unclear due to errors.*

FDA Label Image

Figure-1.jpg (Figure 1)

The text describes a figure labeled Figure 1 that shows the mean concentration of Tizanidine over time for tablets and capsules of 2 x 4 mg under both fasted and fed conditions.*

FDA Label Image

Figure-2.jpg (Figure 2)

The text describes a figure (Figure 2) that shows the change in muscle tone after a single dose study, as measured by the Ashworth Scale with 95% confidence interval. A negative Ashworth score indicates an improvement in muscle tone from baseline. The figure is plotted against hours post-dose.*

FDA Label Image

Figure-3.jpg (Figure 3)

FDA Label Image

Chemical-structure (Tizanidine Imtb 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.